RET and medullary thyroid gland carcinoma: Germline RET variants were identified in eight of 56 subjects with apparently sporadic MTC (14.3%, slightly higher than the 4–10% reported in the literature [26,45,46,47]), confirming the importance of screening RET in all cases of MTC, even when the family history is negative [48].